Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To evaluate the tolerability and safety of SHR-8068 in combination with Adebrelimab and Bevacizumab in subjects with advanced HCC; To evaluate the efficacy of SHR-8068 in combination with Adebrelimab and Bevacizumab in subjects with advanced HCC.
Epistemonikos ID: 6face05a4bc2c02b39b41d6b678deeebcb4b7881
First added on: May 13, 2024